US Stock MarketDetailed Quotes

KPTI Karyopharm Therapeutics

Watchlist

0.724
+0.017+2.46%

Close Sep 27 16:00 ET

0.724
0.0000.00%

Post 20:02 ET

90.26MMarket Cap-635P/E (TTM)

Karyopharm Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Total revenue

13.86%42.79M

-14.40%33.13M

-7.03%146.03M

0.50%33.75M

-0.38%36.01M

-5.29%37.58M

-18.82%38.7M

-25.14%157.07M

-73.41%33.58M

-4.10%36.15M

Operating revenue

13.86%42.79M

-14.40%33.13M

-7.03%146.03M

0.50%33.75M

-0.38%36.01M

-5.29%37.58M

-18.82%38.7M

-25.14%157.07M

-73.41%33.58M

-4.10%36.15M

Cost of revenue

22.70%1.47M

41.45%1.91M

-5.20%4.94M

-20.45%1.49M

-7.04%911K

27.16%1.19M

-5.26%1.35M

53.23%5.21M

151.75%1.87M

66.38%980K

Gross profit

13.57%41.32M

-16.42%31.22M

-7.09%141.09M

1.73%32.26M

-0.19%35.1M

-6.08%36.39M

-19.24%37.35M

-26.43%151.86M

-74.74%31.71M

-5.22%35.17M

Operating expense

5.28%69.44M

-4.79%64.97M

-7.97%270.63M

6.84%70.07M

0.54%66.36M

-19.22%65.96M

-15.57%68.25M

-3.49%294.06M

-16.53%65.58M

-18.42%66M

Selling and administrative expenses

-9.89%31.07M

-17.71%29.55M

-9.30%131.88M

-11.43%30.69M

-11.08%30.81M

-7.65%34.48M

-7.38%35.91M

1.08%145.4M

0.25%34.65M

-1.31%34.65M

-General and administrative expense

-9.89%31.07M

-17.71%29.55M

-9.30%131.88M

-11.43%30.69M

-11.08%30.81M

-7.65%34.48M

-7.38%35.91M

1.08%145.4M

0.25%34.65M

-1.31%34.65M

Research and development costs

21.90%38.37M

9.54%35.43M

-6.67%138.75M

27.31%39.38M

13.37%35.55M

-28.96%31.48M

-23.12%32.34M

-7.57%148.66M

-29.70%30.93M

-31.54%31.36M

Operating profit

4.91%-28.12M

-9.26%-33.76M

8.90%-129.54M

-11.63%-37.81M

-1.37%-31.26M

31.08%-29.57M

10.66%-30.9M

-44.70%-142.2M

-172.12%-33.87M

29.61%-30.84M

Net non-operating interest income expense

-137.13%-7.02M

-28.15%-3.73M

43.10%-12.88M

18.96%-3.69M

39.09%-3.32M

50.83%-2.96M

55.99%-2.91M

11.10%-22.64M

42.28%-4.55M

31.04%-5.46M

Non-operating interest income

-31.66%1.93M

-24.32%2.16M

363.88%10.94M

88.91%2.52M

317.93%2.75M

863.82%2.82M

3,750.00%2.85M

305.33%2.36M

2,325.45%1.33M

571.43%658K

Non-operating interest expense

54.72%8.95M

2.19%5.88M

-4.69%23.82M

5.49%6.21M

-0.67%6.07M

-8.38%5.78M

-13.85%5.76M

-4.03%25M

-25.88%5.89M

-23.67%6.11M

Other net income (expense)

196,560.00%59M

174.24%196K

-328.92%-356K

-1,523.08%-211K

456.25%89K

330.77%30K

-261.64%-264K

2.35%-83K

97.28%-13K

-11.11%16K

Special income (charges)

--44.7M

----

--0

----

-Less:Other special charges

---44.7M

----

Other non- operating income (expenses)

47,553.33%14.3M

174.24%196K

-328.92%-356K

-1,523.08%-211K

456.25%89K

330.77%30K

---264K

2.35%-83K

97.28%-13K

-11.11%16K

Income before tax

173.41%23.86M

-9.45%-37.29M

13.43%-142.78M

-8.52%-41.71M

4.92%-34.49M

33.59%-32.5M

17.44%-34.07M

-33.19%-164.92M

-199.57%-38.43M

29.84%-36.28M

Income tax

-47.24%67K

31.48%71K

-12.47%323K

78.08%130K

-73.33%12K

4.96%127K

-58.46%54K

37.69%369K

160.33%73K

-57.55%45K

Net income

172.91%23.79M

-9.48%-37.36M

13.43%-143.1M

-8.65%-41.84M

5.00%-34.51M

33.49%-32.63M

17.57%-34.13M

-33.20%-165.29M

-199.45%-38.51M

29.89%-36.32M

Net income continuous Operations

172.91%23.79M

-9.48%-37.36M

13.43%-143.1M

-8.65%-41.84M

5.00%-34.51M

33.49%-32.63M

17.57%-34.13M

-33.20%-165.29M

-199.45%-38.51M

29.89%-36.32M

Minority interest income

Net income attributable to the parent company

172.91%23.79M

-9.48%-37.36M

13.43%-143.1M

-8.65%-41.84M

5.00%-34.51M

33.49%-32.63M

17.57%-34.13M

-33.20%-165.29M

-199.45%-38.51M

29.89%-36.32M

Preferred stock dividends

Other preferred stock dividends

5.54M

Net income attributable to common stockholders

155.93%18.25M

-9.48%-37.36M

13.43%-143.1M

-8.65%-41.84M

5.00%-34.51M

33.49%-32.63M

17.57%-34.13M

-33.20%-165.29M

-199.45%-38.51M

29.89%-36.32M

Basic earnings per share

151.72%0.15

-6.67%-0.32

38.12%-1.25

16.28%-0.36

33.33%-0.3

53.23%-0.29

43.40%-0.3

-22.42%-2.02

-184.31%-0.43

34.78%-0.45

Diluted earnings per share

31.03%-0.2

-6.67%-0.32

38.12%-1.25

16.28%-0.36

33.33%-0.3

53.23%-0.29

43.40%-0.3

-22.42%-2.02

-193.48%-0.43

34.78%-0.45

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Total revenue	13.86%42.79M	-14.40%33.13M	-7.03%146.03M	0.50%33.75M	-0.38%36.01M	-5.29%37.58M	-18.82%38.7M	-25.14%157.07M	-73.41%33.58M	-4.10%36.15M
Operating revenue	13.86%42.79M	-14.40%33.13M	-7.03%146.03M	0.50%33.75M	-0.38%36.01M	-5.29%37.58M	-18.82%38.7M	-25.14%157.07M	-73.41%33.58M	-4.10%36.15M
Cost of revenue	22.70%1.47M	41.45%1.91M	-5.20%4.94M	-20.45%1.49M	-7.04%911K	27.16%1.19M	-5.26%1.35M	53.23%5.21M	151.75%1.87M	66.38%980K
Gross profit	13.57%41.32M	-16.42%31.22M	-7.09%141.09M	1.73%32.26M	-0.19%35.1M	-6.08%36.39M	-19.24%37.35M	-26.43%151.86M	-74.74%31.71M	-5.22%35.17M
Operating expense	5.28%69.44M	-4.79%64.97M	-7.97%270.63M	6.84%70.07M	0.54%66.36M	-19.22%65.96M	-15.57%68.25M	-3.49%294.06M	-16.53%65.58M	-18.42%66M
Selling and administrative expenses	-9.89%31.07M	-17.71%29.55M	-9.30%131.88M	-11.43%30.69M	-11.08%30.81M	-7.65%34.48M	-7.38%35.91M	1.08%145.4M	0.25%34.65M	-1.31%34.65M
-General and administrative expense	-9.89%31.07M	-17.71%29.55M	-9.30%131.88M	-11.43%30.69M	-11.08%30.81M	-7.65%34.48M	-7.38%35.91M	1.08%145.4M	0.25%34.65M	-1.31%34.65M
Research and development costs	21.90%38.37M	9.54%35.43M	-6.67%138.75M	27.31%39.38M	13.37%35.55M	-28.96%31.48M	-23.12%32.34M	-7.57%148.66M	-29.70%30.93M	-31.54%31.36M
Operating profit	4.91%-28.12M	-9.26%-33.76M	8.90%-129.54M	-11.63%-37.81M	-1.37%-31.26M	31.08%-29.57M	10.66%-30.9M	-44.70%-142.2M	-172.12%-33.87M	29.61%-30.84M
Net non-operating interest income expense	-137.13%-7.02M	-28.15%-3.73M	43.10%-12.88M	18.96%-3.69M	39.09%-3.32M	50.83%-2.96M	55.99%-2.91M	11.10%-22.64M	42.28%-4.55M	31.04%-5.46M
Non-operating interest income	-31.66%1.93M	-24.32%2.16M	363.88%10.94M	88.91%2.52M	317.93%2.75M	863.82%2.82M	3,750.00%2.85M	305.33%2.36M	2,325.45%1.33M	571.43%658K
Non-operating interest expense	54.72%8.95M	2.19%5.88M	-4.69%23.82M	5.49%6.21M	-0.67%6.07M	-8.38%5.78M	-13.85%5.76M	-4.03%25M	-25.88%5.89M	-23.67%6.11M
Other net income (expense)	196,560.00%59M	174.24%196K	-328.92%-356K	-1,523.08%-211K	456.25%89K	330.77%30K	-261.64%-264K	2.35%-83K	97.28%-13K	-11.11%16K
Special income (charges)	--44.7M	----	----	----	----	--0	----	----	----	----
-Less:Other special charges	---44.7M	----	----	----	----	----	----	----	----	----
Other non- operating income (expenses)	47,553.33%14.3M	174.24%196K	-328.92%-356K	-1,523.08%-211K	456.25%89K	330.77%30K	---264K	2.35%-83K	97.28%-13K	-11.11%16K
Income before tax	173.41%23.86M	-9.45%-37.29M	13.43%-142.78M	-8.52%-41.71M	4.92%-34.49M	33.59%-32.5M	17.44%-34.07M	-33.19%-164.92M	-199.57%-38.43M	29.84%-36.28M
Income tax	-47.24%67K	31.48%71K	-12.47%323K	78.08%130K	-73.33%12K	4.96%127K	-58.46%54K	37.69%369K	160.33%73K	-57.55%45K
Net income	172.91%23.79M	-9.48%-37.36M	13.43%-143.1M	-8.65%-41.84M	5.00%-34.51M	33.49%-32.63M	17.57%-34.13M	-33.20%-165.29M	-199.45%-38.51M	29.89%-36.32M
Net income continuous Operations	172.91%23.79M	-9.48%-37.36M	13.43%-143.1M	-8.65%-41.84M	5.00%-34.51M	33.49%-32.63M	17.57%-34.13M	-33.20%-165.29M	-199.45%-38.51M	29.89%-36.32M
Minority interest income
Net income attributable to the parent company	172.91%23.79M	-9.48%-37.36M	13.43%-143.1M	-8.65%-41.84M	5.00%-34.51M	33.49%-32.63M	17.57%-34.13M	-33.20%-165.29M	-199.45%-38.51M	29.89%-36.32M
Preferred stock dividends
Other preferred stock dividends	5.54M
Net income attributable to common stockholders	155.93%18.25M	-9.48%-37.36M	13.43%-143.1M	-8.65%-41.84M	5.00%-34.51M	33.49%-32.63M	17.57%-34.13M	-33.20%-165.29M	-199.45%-38.51M	29.89%-36.32M
Basic earnings per share	151.72%0.15	-6.67%-0.32	38.12%-1.25	16.28%-0.36	33.33%-0.3	53.23%-0.29	43.40%-0.3	-22.42%-2.02	-184.31%-0.43	34.78%-0.45
Diluted earnings per share	31.03%-0.2	-6.67%-0.32	38.12%-1.25	16.28%-0.36	33.33%-0.3	53.23%-0.29	43.40%-0.3	-22.42%-2.02	-193.48%-0.43	34.78%-0.45
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data